MA (EU) Number
(Invented) 
name
Strength
Pharmaceutical 
Form
Route of 
Administration
Immediate 
Packaging
Content 
(concentration)
Pack size
EU/1/21/1617/001
NGENLA  
EU/1/21/1617/002
NGENLA  
24 mg/ 
1.2 ml
60 mg/ 
1.2 ml
Solution for 
injection
Solution for 
injection
Subcutaneous 
use
Subcutaneous 
use
cartridge (glass) in 
a pre-filled pen
cartridge (glass) in 
a pre-filled pen
1.2 ml (20 
mg/ml)
1.2 ml (50 
mg/ml)
1 pre-filled pen 
1 pre-filled pen 
1|1
